By Ryan Harroff ( January 5, 2023, 5:46 PM EST) -- Israeli biotechnology company BioLine misled the public and its shareholders about its financing shortfalls for a new blood therapy, then ultimately caused a 33% stock drop when it made moves to shore up funding for the product's commercial launch, according to a lawsuit filed Thursday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.